Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrin-mediated focal adhesion kinase and Akt activation (Q39713485)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 April 2010

Language	Label	Description	Also known as
English	Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrin-mediated focal adhesion kinase and Akt activation	scientific article published on 19 April 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrin-mediated focal adhesion kinase and Akt activation (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

D Lane

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

N Goncharenko-Khaider

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

C Rancourt

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

A Piché

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

0 references

publication date

19 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

3519-3531

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Migration properties of the human ovarian adenocarcinoma cell line IGROV1: importance of alpha(v)beta3 integrins and vitronectin

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Integrins as novel drug targets for overcoming innate drug resistance.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Phosphatidylinositol-3-OH kinase/AKT and survivin pathways as critical targets for geranylgeranyltransferase I inhibitor-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Fibronectin Protects Prostate Cancer Cells from Tumor Necrosis Factor-α-induced Apoptosis via the AKT/Survivin Pathway

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Integrins and anoikis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Proinvasive properties of ovarian cancer ascites-derived membrane vesicles

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Integrins: versatility, modulation, and signaling in cell adhesion

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

A signaling pathway from the alpha5beta1 and alpha(v)beta3 integrins that elevates bcl-2 transcription

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

The emerging role of lysophosphatidic acid in cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

The prognostic implication of ascites in advanced-stage ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Role of insulin-like growth factor-I in regulating estrogen receptor-alpha gene expression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Get a ligand, get a life: integrins, signaling and cell survival

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Malignant effusions contain lysophosphatidic acid (LPA)-like activity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Lysophosphatidic acid as a novel cell survival/apoptotic factor.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

21 January 2018

Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

31 March 2020

Lysophosphatidic acid receptors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

31 March 2020

Role of alphav integrin in osteoprotegerin-induced endothelial cell migration and proliferation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

31 March 2020

Epidermal growth factor receptor and transforming growth factor alpha expression in human ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

31 March 2020

Cell detachment modulates TRAIL resistance in ovarian cancer cells by downregulating the phosphatidylinositol 3-kinase/Akt pathway

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

31 March 2020

Transforming growth factor-alpha levels in the serum and ascites of patients with advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

31 March 2020

Ascites as a predictor of ovarian malignancy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

31 March 2020

Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.107

31 March 2020

Identifiers

10.1038/ONC.2010.107

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39713485&oldid=2203117902"